These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30827683)

  • 1. Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling.
    Pan L; Fu TM; Zhao W; Zhao L; Chen W; Qiu C; Liu W; Liu Z; Piai A; Fu Q; Chen S; Wu H; Chou JJ
    Cell; 2019 Mar; 176(6):1477-1489.e14. PubMed ID: 30827683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death Receptor 5 Networks Require Membrane Cholesterol for Proper Structure and Function.
    Lewis AK; Valley CC; Peery SL; Brummel B; Braun AR; Karim CB; Sachs JN
    J Mol Biol; 2016 Dec; 428(24 Pt A):4843-4855. PubMed ID: 27720987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation.
    Du G; Zhao L; Zheng Y; Belfetmi A; Cai T; Xu B; Heyninck K; Van Den Heede K; Buyse MA; Fontana P; Bowman M; Lin LL; Wu H; Chou JJ
    Cell Res; 2023 Feb; 33(2):131-146. PubMed ID: 36604598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors.
    Zhao L; Fu Q; Pan L; Piai A; Chou JJ
    Front Cell Dev Biol; 2020; 8():569684. PubMed ID: 33163490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5.
    Adams C; Totpal K; Lawrence D; Marsters S; Pitti R; Yee S; Ross S; Deforge L; Koeppen H; Sagolla M; Compaan D; Lowman H; Hymowitz S; Ashkenazi A
    Cell Death Differ; 2008 Apr; 15(4):751-61. PubMed ID: 18219321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study.
    Wassenaar TA; Quax WJ; Mark AE
    Proteins; 2008 Feb; 70(2):333-43. PubMed ID: 17671978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
    Fancy RM; Wang L; Zeng Q; Wang H; Zhou T; Buchsbaum DJ; Song Y
    J Biol Chem; 2016 Jun; 291(24):12862-12870. PubMed ID: 27129269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand dimerization programmed by hybridization to study multimeric ligand-receptor interactions.
    Gorska K; Beyrath J; Fournel S; Guichard G; Winssinger N
    Chem Commun (Camb); 2010 Nov; 46(41):7742-4. PubMed ID: 20852806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Extracellular Domain of Death Receptor 5 Inhibits TRAIL-Induced Apoptosis by Disrupting Receptor-Receptor Interactions.
    Vunnam N; Lo CH; Grant BD; Thomas DD; Sachs JN
    J Mol Biol; 2017 Sep; 429(19):2943-2953. PubMed ID: 28834692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity.
    Guillaume YC; Lethier L; André C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():142-148. PubMed ID: 27750195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
    Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
    J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X receptor induces cell death and sensitizes to TRAIL-induced inhibition of growth in colorectal cancer cells through the up-regulation of death receptor 5.
    Hotta M; Sakatani T; Ishino K; Wada R; Kudo M; Yokoyama Y; Yamada T; Yoshida H; Naito Z
    Biochem Biophys Res Commun; 2019 Nov; 519(4):824-831. PubMed ID: 31561852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing.
    Oh YT; Deng J; Yue P; Owonikoko TK; Khuri FR; Sun SY
    Oncogene; 2016 Jan; 35(4):459-67. PubMed ID: 25867065
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Baudin A; Guichard A; Collie GW; Rousseau S; Chaignepain S; Hocquellet A; Berbon M; Loquet A; Mackereth C; Guichard G; Odaert B
    Biomol NMR Assign; 2018 Oct; 12(2):309-314. PubMed ID: 29869749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K; Narayan P; Simon JP; Puett D
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL-induced caspase activation.
    Wu Y; Kimura Y; Okamoto T; Matsuhisa K; Asada R; Saito A; Sakaue F; Imaizumi K; Kaneko M
    Sci Rep; 2019 Dec; 9(1):20301. PubMed ID: 31889078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
    Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
    FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.